Filtered By:
Source: Journal of Drugs in Dermatology
This page shows you your search results in order of date. This is page number 3.
Order by Relevance | Date
Total 900 results found since Jan 2013.
A Review of Tapinarof: Novel Topical Treatment for Plaque Psoriasis in Adults
J Drugs Dermatol. 2023 Aug 1;22(8):761-765. doi: 10.36849/jdd.7481.ABSTRACTPsoriasis is a chronic, immune-mediated, multisystem, inflammatory dermatological condition that is persistent and relapsing. Topical treatments are first line agents for mild to moderate plaque psoriasis. With proven efficacy and safety, topical corticosteroids are often used, although adverse effects and limitations for use exist. Tapinarof (Vtama®), a novel topical aryl hydrocarbon receptor modulating drug, was approved by the US Food and Drug Administration for the treatment of plaque psoriasis in adults in May 2022. A literature search ...
Source: Journal of Drugs in Dermatology - August 9, 2023 Category: Dermatology Authors: Julie Kalabalik-Hoganson Anna Nogid Kathleen Frey Source Type: research
Dermatology in Contemporary Times: Building Awareness of Social Media's Association With Adolescent Skin Disease and Mental Health
Conclusions: The association with negative life events, BDD, suicidal ideation, depression, and anxiety are thought to be high for adolescent patients with acne or AD. Using social media for information has both positive and negative aspects. Awareness of the risks and benefits of receiving health information about dermatological disease among adolescents needs to be improved through the education of patients and clinicians. Action-oriented items need to be developed to help dermatologists address these issues in clinical practice.Rieder EA, Andriessen A, Cutler V, et al. Dermatology in contemporary times: building awarene...
Source: Journal of Drugs in Dermatology - August 9, 2023 Category: Dermatology Authors: Evan A Rieder Anneke Andriessen Vanessa Cutler Mercedes E Gonzalez Jennifer L Greenberg Peter Lio Elyse M Love Joyce H Park Hinke Andriessen Katharine A Phillips Source Type: research
A Review of Tapinarof: Novel Topical Treatment for Plaque Psoriasis in Adults
J Drugs Dermatol. 2023 Aug 1;22(8):761-765. doi: 10.36849/jdd.7481.ABSTRACTPsoriasis is a chronic, immune-mediated, multisystem, inflammatory dermatological condition that is persistent and relapsing. Topical treatments are first line agents for mild to moderate plaque psoriasis. With proven efficacy and safety, topical corticosteroids are often used, although adverse effects and limitations for use exist. Tapinarof (Vtama®), a novel topical aryl hydrocarbon receptor modulating drug, was approved by the US Food and Drug Administration for the treatment of plaque psoriasis in adults in May 2022. A literature search ...
Source: Journal of Drugs in Dermatology - August 9, 2023 Category: Dermatology Authors: Julie Kalabalik-Hoganson Anna Nogid Kathleen Frey Source Type: research
Dermatology in Contemporary Times: Building Awareness of Social Media's Association With Adolescent Skin Disease and Mental Health
Conclusions: The association with negative life events, BDD, suicidal ideation, depression, and anxiety are thought to be high for adolescent patients with acne or AD. Using social media for information has both positive and negative aspects. Awareness of the risks and benefits of receiving health information about dermatological disease among adolescents needs to be improved through the education of patients and clinicians. Action-oriented items need to be developed to help dermatologists address these issues in clinical practice.Rieder EA, Andriessen A, Cutler V, et al. Dermatology in contemporary times: building awarene...
Source: Journal of Drugs in Dermatology - August 9, 2023 Category: Dermatology Authors: Evan A Rieder Anneke Andriessen Vanessa Cutler Mercedes E Gonzalez Jennifer L Greenberg Peter Lio Elyse M Love Joyce H Park Hinke Andriessen Katharine A Phillips Source Type: research
A Review of Tapinarof: Novel Topical Treatment for Plaque Psoriasis in Adults
J Drugs Dermatol. 2023 Aug 1;22(8):761-765. doi: 10.36849/jdd.7481.ABSTRACTPsoriasis is a chronic, immune-mediated, multisystem, inflammatory dermatological condition that is persistent and relapsing. Topical treatments are first line agents for mild to moderate plaque psoriasis. With proven efficacy and safety, topical corticosteroids are often used, although adverse effects and limitations for use exist. Tapinarof (Vtama®), a novel topical aryl hydrocarbon receptor modulating drug, was approved by the US Food and Drug Administration for the treatment of plaque psoriasis in adults in May 2022. A literature search ...
Source: Journal of Drugs in Dermatology - August 9, 2023 Category: Dermatology Authors: Julie Kalabalik-Hoganson Anna Nogid Kathleen Frey Source Type: research
Dermatology in Contemporary Times: Building Awareness of Social Media's Association With Adolescent Skin Disease and Mental Health
Conclusions: The association with negative life events, BDD, suicidal ideation, depression, and anxiety are thought to be high for adolescent patients with acne or AD. Using social media for information has both positive and negative aspects. Awareness of the risks and benefits of receiving health information about dermatological disease among adolescents needs to be improved through the education of patients and clinicians. Action-oriented items need to be developed to help dermatologists address these issues in clinical practice.Rieder EA, Andriessen A, Cutler V, et al. Dermatology in contemporary times: building awarene...
Source: Journal of Drugs in Dermatology - August 9, 2023 Category: Dermatology Authors: Evan A Rieder Anneke Andriessen Vanessa Cutler Mercedes E Gonzalez Jennifer L Greenberg Peter Lio Elyse M Love Joyce H Park Hinke Andriessen Katharine A Phillips Source Type: research
A Review of Tapinarof: Novel Topical Treatment for Plaque Psoriasis in Adults
J Drugs Dermatol. 2023 Aug 1;22(8):761-765. doi: 10.36849/jdd.7481.ABSTRACTPsoriasis is a chronic, immune-mediated, multisystem, inflammatory dermatological condition that is persistent and relapsing. Topical treatments are first line agents for mild to moderate plaque psoriasis. With proven efficacy and safety, topical corticosteroids are often used, although adverse effects and limitations for use exist. Tapinarof (Vtama®), a novel topical aryl hydrocarbon receptor modulating drug, was approved by the US Food and Drug Administration for the treatment of plaque psoriasis in adults in May 2022. A literature search ...
Source: Journal of Drugs in Dermatology - August 9, 2023 Category: Dermatology Authors: Julie Kalabalik-Hoganson Anna Nogid Kathleen Frey Source Type: research
Dermatology in Contemporary Times: Building Awareness of Social Media's Association With Adolescent Skin Disease and Mental Health
Conclusions: The association with negative life events, BDD, suicidal ideation, depression, and anxiety are thought to be high for adolescent patients with acne or AD. Using social media for information has both positive and negative aspects. Awareness of the risks and benefits of receiving health information about dermatological disease among adolescents needs to be improved through the education of patients and clinicians. Action-oriented items need to be developed to help dermatologists address these issues in clinical practice.Rieder EA, Andriessen A, Cutler V, et al. Dermatology in contemporary times: building awarene...
Source: Journal of Drugs in Dermatology - August 9, 2023 Category: Dermatology Authors: Evan A Rieder Anneke Andriessen Vanessa Cutler Mercedes E Gonzalez Jennifer L Greenberg Peter Lio Elyse M Love Joyce H Park Hinke Andriessen Katharine A Phillips Source Type: research
A Review of Tapinarof: Novel Topical Treatment for Plaque Psoriasis in Adults
J Drugs Dermatol. 2023 Aug 1;22(8):761-765. doi: 10.36849/jdd.7481.ABSTRACTPsoriasis is a chronic, immune-mediated, multisystem, inflammatory dermatological condition that is persistent and relapsing. Topical treatments are first line agents for mild to moderate plaque psoriasis. With proven efficacy and safety, topical corticosteroids are often used, although adverse effects and limitations for use exist. Tapinarof (Vtama®), a novel topical aryl hydrocarbon receptor modulating drug, was approved by the US Food and Drug Administration for the treatment of plaque psoriasis in adults in May 2022. A literature search ...
Source: Journal of Drugs in Dermatology - August 9, 2023 Category: Dermatology Authors: Julie Kalabalik-Hoganson Anna Nogid Kathleen Frey Source Type: research
Dermatology in Contemporary Times: Building Awareness of Social Media's Association With Adolescent Skin Disease and Mental Health
Conclusions: The association with negative life events, BDD, suicidal ideation, depression, and anxiety are thought to be high for adolescent patients with acne or AD. Using social media for information has both positive and negative aspects. Awareness of the risks and benefits of receiving health information about dermatological disease among adolescents needs to be improved through the education of patients and clinicians. Action-oriented items need to be developed to help dermatologists address these issues in clinical practice.Rieder EA, Andriessen A, Cutler V, et al. Dermatology in contemporary times: building awarene...
Source: Journal of Drugs in Dermatology - August 9, 2023 Category: Dermatology Authors: Evan A Rieder Anneke Andriessen Vanessa Cutler Mercedes E Gonzalez Jennifer L Greenberg Peter Lio Elyse M Love Joyce H Park Hinke Andriessen Katharine A Phillips Source Type: research
A Review of Tapinarof: Novel Topical Treatment for Plaque Psoriasis in Adults
J Drugs Dermatol. 2023 Aug 1;22(8):761-765. doi: 10.36849/jdd.7481.ABSTRACTPsoriasis is a chronic, immune-mediated, multisystem, inflammatory dermatological condition that is persistent and relapsing. Topical treatments are first line agents for mild to moderate plaque psoriasis. With proven efficacy and safety, topical corticosteroids are often used, although adverse effects and limitations for use exist. Tapinarof (Vtama®), a novel topical aryl hydrocarbon receptor modulating drug, was approved by the US Food and Drug Administration for the treatment of plaque psoriasis in adults in May 2022. A literature search ...
Source: Journal of Drugs in Dermatology - August 9, 2023 Category: Dermatology Authors: Julie Kalabalik-Hoganson Anna Nogid Kathleen Frey Source Type: research
Dermatology in Contemporary Times: Building Awareness of Social Media's Association With Adolescent Skin Disease and Mental Health
Conclusions: The association with negative life events, BDD, suicidal ideation, depression, and anxiety are thought to be high for adolescent patients with acne or AD. Using social media for information has both positive and negative aspects. Awareness of the risks and benefits of receiving health information about dermatological disease among adolescents needs to be improved through the education of patients and clinicians. Action-oriented items need to be developed to help dermatologists address these issues in clinical practice.Rieder EA, Andriessen A, Cutler V, et al. Dermatology in contemporary times: building awarene...
Source: Journal of Drugs in Dermatology - August 9, 2023 Category: Dermatology Authors: Evan A Rieder Anneke Andriessen Vanessa Cutler Mercedes E Gonzalez Jennifer L Greenberg Peter Lio Elyse M Love Joyce H Park Hinke Andriessen Katharine A Phillips Source Type: research
Skin of Color Sun Protection: Reddit Analysis Reveals Perceptions, Preferences, Unmet Needs, and Knowledge Gaps
CONCLUSIONS: Analysis of Reddit posts regarding photoprotection in skin of color yields valuable insights into the perceptions, preferences, unmet needs, and knowledge gaps regarding sun protection for this group of patients. Physicians can use this information to better educate patients and improve photoprotection adherence. This information is also valuable for pharmaceutical and sun protection industries that can use these insights to fill unmet sunscreen needs for patients of color. Mineroff J, Kurtti A, Jagdeo J. Skin of color sun protection: reddit analysis reveals perceptions, preferences, unmet needs, and...
Source: Journal of Drugs in Dermatology - July 6, 2023 Category: Dermatology Authors: Jessica Mineroff Alana Kurtti Jared Jagdeo Source Type: research
